array(40) {
  [0]=>
  string(4) "8688"
  ["article_id"]=>
  string(4) "8688"
  [1]=>
  string(37) "What is a clinical evaluation report?"
  ["article_title"]=>
  string(37) "What is a clinical evaluation report?"
  [2]=>
  string(142) "Ramya Sriram, digital content manager at Kolabtree, an online freelance platform for scientists, discusses Clinical Evaluation Reports (CERs)."
  ["short_description"]=>
  string(142) "Ramya Sriram, digital content manager at Kolabtree, an online freelance platform for scientists, discusses Clinical Evaluation Reports (CERs)."
  [3]=>
  string(142) "Ramya Sriram, digital content manager at Kolabtree, an online freelance platform for scientists, discusses Clinical Evaluation Reports (CERs)."
  ["description"]=>
  string(142) "Ramya Sriram, digital content manager at Kolabtree, an online freelance platform for scientists, discusses Clinical Evaluation Reports (CERs)."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(78) "https://www.medicalplasticsnews.com/news/what-is-a-clinical-evaluation-report/"
  ["blog_url"]=>
  string(78) "https://www.medicalplasticsnews.com/news/what-is-a-clinical-evaluation-report/"
  [15]=>
  string(19) "2020-03-27 18:41:58"
  ["add_date"]=>
  string(19) "2020-03-27 18:41:58"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8709"
  ["article_id"]=>
  string(4) "8709"
  [1]=>
  string(30) "FDA to transition NDAs to BLAs"
  ["article_title"]=>
  string(30) "FDA to transition NDAs to BLAs"
  [2]=>
  string(150) "The US Food and Drug Administration (FDA) is soon to transition many new drug applications (NDAs) to biologicals license applications (BLAs), with sig"
  ["short_description"]=>
  string(150) "The US Food and Drug Administration (FDA) is soon to transition many new drug applications (NDAs) to biologicals license applications (BLAs), with sig"
  [3]=>
  string(228) "
The US Food and Drug Administration (FDA) is soon to transition many new drug applications (NDAs) to biologicals license applications (BLAs), with significant implications for biotechnology companies and drug compounders.
"
  ["description"]=>
  string(228) "
The US Food and Drug Administration (FDA) is soon to transition many new drug applications (NDAs) to biologicals license applications (BLAs), with significant implications for biotechnology companies and drug compounders.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "42"
  ["rss_id"]=>
  string(2) "42"
  [14]=>
  string(68) "http://www.gabionline.net//Guidelines/FDA-to-transition-NDAs-to-BLAs"
  ["blog_url"]=>
  string(68) "http://www.gabionline.net//Guidelines/FDA-to-transition-NDAs-to-BLAs"
  [15]=>
  string(19) "2020-03-27 17:56:11"
  ["add_date"]=>
  string(19) "2020-03-27 17:56:11"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:41"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8710"
  ["article_id"]=>
  string(4) "8710"
  [1]=>
  string(54) "Denosumab copy biological accepted for review in China"
  ["article_title"]=>
  string(54) "Denosumab copy biological accepted for review in China"
  [2]=>
  string(155) "China’s National Medical Products Administration (NMPA), formerly the China Food and Drug Administration (CFDA), has accepted an application for the"
  ["short_description"]=>
  string(155) "China’s National Medical Products Administration (NMPA), formerly the China Food and Drug Administration (CFDA), has accepted an application for the"
  [3]=>
  string(207) "
China’s National Medical Products Administration (NMPA), formerly the China Food and Drug Administration (CFDA), has accepted an application for the approval of denosumab copy biological HLX14.
"
  ["description"]=>
  string(207) "
China’s National Medical Products Administration (NMPA), formerly the China Food and Drug Administration (CFDA), has accepted an application for the approval of denosumab copy biological HLX14.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "42"
  ["rss_id"]=>
  string(2) "42"
  [14]=>
  string(98) "http://www.gabionline.net//Biosimilars/News/Denosumab-copy-biological-accepted-for-review-in-China"
  ["blog_url"]=>
  string(98) "http://www.gabionline.net//Biosimilars/News/Denosumab-copy-biological-accepted-for-review-in-China"
  [15]=>
  string(19) "2020-03-27 17:53:36"
  ["add_date"]=>
  string(19) "2020-03-27 17:53:36"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:41"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8711"
  ["article_id"]=>
  string(4) "8711"
  [1]=>
  string(64) "Roche continues litigation in India and receives fine in Romania"
  ["article_title"]=>
  string(64) "Roche continues litigation in India and receives fine in Romania"
  [2]=>
  string(150) "Switzerland-based pharmaceutical giant Roche is continuing to pursue legal action in India over a trastuzumab similar biologic and has recently been f"
  ["short_description"]=>
  string(150) "Switzerland-based pharmaceutical giant Roche is continuing to pursue legal action in India over a trastuzumab similar biologic and has recently been f"
  [3]=>
  string(225) "
Switzerland-based pharmaceutical giant Roche is continuing to pursue legal action in India over a trastuzumab similar biologic and has recently been fined in Romania for delaying the entry of biosimilars to the market.
"
  ["description"]=>
  string(225) "
Switzerland-based pharmaceutical giant Roche is continuing to pursue legal action in India over a trastuzumab similar biologic and has recently been fined in Romania for delaying the entry of biosimilars to the market.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "42"
  ["rss_id"]=>
  string(2) "42"
  [14]=>
  string(103) "http://www.gabionline.net//Pharma-News/Roche-continues-litigation-in-India-and-receives-fine-in-Romania"
  ["blog_url"]=>
  string(103) "http://www.gabionline.net//Pharma-News/Roche-continues-litigation-in-India-and-receives-fine-in-Romania"
  [15]=>
  string(19) "2020-03-27 17:47:44"
  ["add_date"]=>
  string(19) "2020-03-27 17:47:44"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:41"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8712"
  ["article_id"]=>
  string(4) "8712"
  [1]=>
  string(58) "Celltrion/Teva launch trastuzumab biosimilar Herzuma in US"
  ["article_title"]=>
  string(58) "Celltrion/Teva launch trastuzumab biosimilar Herzuma in US"
  [2]=>
  string(150) "Celltrion and Teva announced in March 2020 that they have launched their trastuzumab biosimilar Herzuma (trastuzumab-pkrb) in the US. Herzuma can be u"
  ["short_description"]=>
  string(150) "Celltrion and Teva announced in March 2020 that they have launched their trastuzumab biosimilar Herzuma (trastuzumab-pkrb) in the US. Herzuma can be u"
  [3]=>
  string(241) "
Celltrion and Teva announced in March 2020 that they have launched their trastuzumab biosimilar Herzuma (trastuzumab-pkrb) in the US. Herzuma can be used to treat breast and gastric cancer and has recently been approved in Canada [1].
"
  ["description"]=>
  string(241) "
Celltrion and Teva announced in March 2020 that they have launched their trastuzumab biosimilar Herzuma (trastuzumab-pkrb) in the US. Herzuma can be used to treat breast and gastric cancer and has recently been approved in Canada [1].
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "42"
  ["rss_id"]=>
  string(2) "42"
  [14]=>
  string(102) "http://www.gabionline.net//Biosimilars/News/Celltrion-Teva-launch-trastuzumab-biosimilar-Herzuma-in-US"
  ["blog_url"]=>
  string(102) "http://www.gabionline.net//Biosimilars/News/Celltrion-Teva-launch-trastuzumab-biosimilar-Herzuma-in-US"
  [15]=>
  string(19) "2020-03-27 17:45:58"
  ["add_date"]=>
  string(19) "2020-03-27 17:45:58"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:41"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8689"
  ["article_id"]=>
  string(4) "8689"
  [1]=>
  string(57) "You can still request anatomical models 24/7 from Axial3D"
  ["article_title"]=>
  string(57) "You can still request anatomical models 24/7 from Axial3D"
  [2]=>
  string(145) "Roger Johnston, CEO of medical 3D printing firm Axial3D, has issued a statement regarding the company’s response to the COVID-19 pandemic."
  ["short_description"]=>
  string(145) "Roger Johnston, CEO of medical 3D printing firm Axial3D, has issued a statement regarding the company’s response to the COVID-19 pandemic."
  [3]=>
  string(145) "Roger Johnston, CEO of medical 3D printing firm Axial3D, has issued a statement regarding the company’s response to the COVID-19 pandemic."
  ["description"]=>
  string(145) "Roger Johnston, CEO of medical 3D printing firm Axial3D, has issued a statement regarding the company’s response to the COVID-19 pandemic."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(98) "https://www.medicalplasticsnews.com/news/you-can-still-request-anatomical-models-247-from-axial3d/"
  ["blog_url"]=>
  string(98) "https://www.medicalplasticsnews.com/news/you-can-still-request-anatomical-models-247-from-axial3d/"
  [15]=>
  string(19) "2020-03-27 17:45:18"
  ["add_date"]=>
  string(19) "2020-03-27 17:45:18"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8713"
  ["article_id"]=>
  string(4) "8713"
  [1]=>
  string(56) "US oncologist says Medicare should not practice medicine"
  ["article_title"]=>
  string(56) "US oncologist says Medicare should not practice medicine"
  [2]=>
  string(150) "Clinical oncologist, Dr Debra Patt, who serves on the US Oncology Research Breast Cancer Committee and chairs the breast cancer subsection of the path"
  ["short_description"]=>
  string(150) "Clinical oncologist, Dr Debra Patt, who serves on the US Oncology Research Breast Cancer Committee and chairs the breast cancer subsection of the path"
  [3]=>
  string(356) "
Clinical oncologist, Dr Debra Patt, who serves on the US Oncology Research Breast Cancer Committee and chairs the breast cancer subsection of the pathways task force for The US Oncology Network, expresses her opinion on a new policy introduced by Medicare, which she believes is ‘having a negative impact on a patient’s outcome’.
"
  ["description"]=>
  string(356) "
Clinical oncologist, Dr Debra Patt, who serves on the US Oncology Research Breast Cancer Committee and chairs the breast cancer subsection of the pathways task force for The US Oncology Network, expresses her opinion on a new policy introduced by Medicare, which she believes is ‘having a negative impact on a patient’s outcome’.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "42"
  ["rss_id"]=>
  string(2) "42"
  [14]=>
  string(103) "http://www.gabionline.net//Biosimilars/General/US-oncologist-says-Medicare-should-not-practice-medicine"
  ["blog_url"]=>
  string(103) "http://www.gabionline.net//Biosimilars/General/US-oncologist-says-Medicare-should-not-practice-medicine"
  [15]=>
  string(19) "2020-03-27 17:40:58"
  ["add_date"]=>
  string(19) "2020-03-27 17:40:58"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:41"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8497"
  ["article_id"]=>
  string(4) "8497"
  [1]=>
  string(68) "Preventing Repeat Heart Attack, Stroke More Important Than Ever: AHA"
  ["article_title"]=>
  string(68) "Preventing Repeat Heart Attack, Stroke More Important Than Ever: AHA"
  [2]=>
  string(150) "FRIDAY, March 27, 2020 -- With the new coronavirus severely straining the U.S. health care system, experts are calling on heart attack and stroke surv"
  ["short_description"]=>
  string(150) "FRIDAY, March 27, 2020 -- With the new coronavirus severely straining the U.S. health care system, experts are calling on heart attack and stroke surv"
  [3]=>
  string(252) "FRIDAY, March 27, 2020 -- With the new coronavirus severely straining the U.S. health care system, experts are calling on heart attack and stroke survivors to take extra steps to reduce their risk of a repeat event.&#nlThe American Heart Association..."
  ["description"]=>
  string(252) "FRIDAY, March 27, 2020 -- With the new coronavirus severely straining the U.S. health care system, experts are calling on heart attack and stroke survivors to take extra steps to reduce their risk of a repeat event.&#nlThe American Heart Association..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(220) "https://www.drugs.com/news/preventing-repeat-heart-attack-stroke-more-important-than-ever-aha-89232.html?utm_source=ddc&utm_medium=rss&utm_campaign=Preventing+Repeat+Heart+Attack%2C+Stroke+More+Important+Than+Ever%3A+AHA"
  ["blog_url"]=>
  string(220) "https://www.drugs.com/news/preventing-repeat-heart-attack-stroke-more-important-than-ever-aha-89232.html?utm_source=ddc&utm_medium=rss&utm_campaign=Preventing+Repeat+Heart+Attack%2C+Stroke+More+Important+Than+Ever%3A+AHA"
  [15]=>
  string(19) "2020-03-27 17:03:36"
  ["add_date"]=>
  string(19) "2020-03-27 17:03:36"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:17:59"
  ["create_at"]=>
  string(19) "2020-03-31 11:17:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8498"
  ["article_id"]=>
  string(4) "8498"
  [1]=>
  string(46) "Legal Pot Products Too Potent for Chronic Pain"
  ["article_title"]=>
  string(46) "Legal Pot Products Too Potent for Chronic Pain"
  [2]=>
  string(150) "FRIDAY, March 27, 2020 -- Most legal medical marijuana -- more than 90% -- is stronger than what doctors recommend for chronic pain relief, a new stud"
  ["short_description"]=>
  string(150) "FRIDAY, March 27, 2020 -- Most legal medical marijuana -- more than 90% -- is stronger than what doctors recommend for chronic pain relief, a new stud"
  [3]=>
  string(257) "FRIDAY, March 27, 2020 -- Most legal medical marijuana -- more than 90% -- is stronger than what doctors recommend for chronic pain relief, a new study finds.&#nl"We know that high-potency products should not have a place in the medical realm because..."
  ["description"]=>
  string(257) "FRIDAY, March 27, 2020 -- Most legal medical marijuana -- more than 90% -- is stronger than what doctors recommend for chronic pain relief, a new study finds.&#nl"We know that high-potency products should not have a place in the medical realm because..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(166) "https://www.drugs.com/news/legal-pot-products-potent-chronic-pain-89230.html?utm_source=ddc&utm_medium=rss&utm_campaign=Legal+Pot+Products+Too+Potent+for+Chronic+Pain"
  ["blog_url"]=>
  string(166) "https://www.drugs.com/news/legal-pot-products-potent-chronic-pain-89230.html?utm_source=ddc&utm_medium=rss&utm_campaign=Legal+Pot+Products+Too+Potent+for+Chronic+Pain"
  [15]=>
  string(19) "2020-03-27 17:03:27"
  ["add_date"]=>
  string(19) "2020-03-27 17:03:27"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:17:59"
  ["create_at"]=>
  string(19) "2020-03-31 11:17:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8499"
  ["article_id"]=>
  string(4) "8499"
  [1]=>
  string(33) "Health Highlights: March 27, 2020"
  ["article_title"]=>
  string(33) "Health Highlights: March 27, 2020"
  [2]=>
  string(156) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nlU.S. Autism Diagnoses Rise, Racial Gap Closes&#nl"
  ["short_description"]=>
  string(156) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nlU.S. Autism Diagnoses Rise, Racial Gap Closes&#nl"
  [3]=>
  string(251) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nlU.S. Autism Diagnoses Rise, Racial Gap Closes&#nlWhile the United States has had a slight increase in diagnosed autism cases, the gap between..."
  ["description"]=>
  string(251) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nlU.S. Autism Diagnoses Rise, Racial Gap Closes&#nlWhile the United States has had a slight increase in diagnosed autism cases, the gap between..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(150) "https://www.drugs.com/news/health-highlights-march-27-2020-89233.html?utm_source=ddc&utm_medium=rss&utm_campaign=Health+Highlights%3A+March+27%2C+2020"
  ["blog_url"]=>
  string(150) "https://www.drugs.com/news/health-highlights-march-27-2020-89233.html?utm_source=ddc&utm_medium=rss&utm_campaign=Health+Highlights%3A+March+27%2C+2020"
  [15]=>
  string(19) "2020-03-27 16:03:46"
  ["add_date"]=>
  string(19) "2020-03-27 16:03:46"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:17:59"
  ["create_at"]=>
  string(19) "2020-03-31 11:17:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8727"
  ["article_id"]=>
  string(4) "8727"
  [1]=>
  string(83) "I might have brought COVID-19 to work in January, is my mom a bad manager, and more"
  ["article_title"]=>
  string(83) "I might have brought COVID-19 to work in January, is my mom a bad manager, and more"
  [2]=>
  string(159) "It’s five answers to five questions. Here we go… 1. Should I tell my employer I may have brought COVID-19 to work in January? I’m hoping you"
  ["short_description"]=>
  string(159) "It’s five answers to five questions. Here we go… 1. Should I tell my employer I may have brought COVID-19 to work in January? I’m hoping you"
  [3]=>
  string(1615) "
It’s five answers to five questions. Here we go… 1. Should I tell my employer I may have brought COVID-19 to work in January? I’m hoping you can help me with an ethical dilemma I am having. Back in mid-January, I took a trip to Northern Italy, where I caught a weird little respiratory virus. […]
&#nl
&#nl
You may also like:
&#nl
&#nl
what to do if your company isn't handling coronavirus well
&#nl
we have a new paid (paid!) sick and family leave law
&#nl
my employee knowingly brought norovirus into the office and got a bunch of people sick
&#nl
&#nl
&#nl
&#nl
I might have brought COVID-19 to work in January, is my mom a bad manager, and more was originally published by Alison Green on Ask a Manager.
&#nl"
  ["description"]=>
  string(1615) "
It’s five answers to five questions. Here we go… 1. Should I tell my employer I may have brought COVID-19 to work in January? I’m hoping you can help me with an ethical dilemma I am having. Back in mid-January, I took a trip to Northern Italy, where I caught a weird little respiratory virus. […]
&#nl
&#nl
You may also like:
&#nl
&#nl
what to do if your company isn't handling coronavirus well
&#nl
we have a new paid (paid!) sick and family leave law
&#nl
my employee knowingly brought norovirus into the office and got a bunch of people sick
&#nl
&#nl
&#nl
&#nl
I might have brought COVID-19 to work in January, is my mom a bad manager, and more was originally published by Alison Green on Ask a Manager.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "5"
  ["category"]=>
  string(1) "5"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "50"
  ["rss_id"]=>
  string(2) "50"
  [14]=>
  string(122) "https://www.askamanager.org/2020/03/i-might-have-brought-covid-19-to-work-in-january-is-my-mom-a-bad-manager-and-more.html"
  ["blog_url"]=>
  string(122) "https://www.askamanager.org/2020/03/i-might-have-brought-covid-19-to-work-in-january-is-my-mom-a-bad-manager-and-more.html"
  [15]=>
  string(19) "2020-03-27 12:03:11"
  ["add_date"]=>
  string(19) "2020-03-27 12:03:11"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:45"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:45"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8664"
  ["article_id"]=>
  string(4) "8664"
  [1]=>
  string(73) "Fusion Pharmaceuticals Taps James O’Leary as Chief Medical Officer"
  ["article_title"]=>
  string(73) "Fusion Pharmaceuticals Taps James O’Leary as Chief Medical Officer"
  [2]=>
  string(160) "Fusion Pharmaceuticals has appointed James O’Leary as its chief medical officer. O’Leary’s experience includes roles at ImmunoGen (NASDAQ: I"
  ["short_description"]=>
  string(160) "Fusion Pharmaceuticals has appointed James O’Leary as its chief medical officer. O’Leary’s experience includes roles at ImmunoGen (NASDAQ: I"
  [3]=>
  string(436) "Fusion Pharmaceuticals has appointed James O’Leary as its chief medical officer. O’Leary’s experience includes roles at ImmunoGen (NASDAQ: IMGN), Idera Pharmaceuticals (NASDAQ: IDRA), Array Biopharma, and Deciphera (NASDAQ: DCPH), Takeda (NYSE: TAK), Bayer, and Pfizer (NYSE: PFE). Most recently O’Leary was a global project team leader for a late-stage asset directing global strategy and regulatory […]"
  ["description"]=>
  string(436) "Fusion Pharmaceuticals has appointed James O’Leary as its chief medical officer. O’Leary’s experience includes roles at ImmunoGen (NASDAQ: IMGN), Idera Pharmaceuticals (NASDAQ: IDRA), Array Biopharma, and Deciphera (NASDAQ: DCPH), Takeda (NYSE: TAK), Bayer, and Pfizer (NYSE: PFE). Most recently O’Leary was a global project team leader for a late-stage asset directing global strategy and regulatory […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(104) "https://xconomy.com/boston/2020/03/26/fusion-pharmaceuticals-taps-james-oleary-as-chief-medical-officer/"
  ["blog_url"]=>
  string(104) "https://xconomy.com/boston/2020/03/26/fusion-pharmaceuticals-taps-james-oleary-as-chief-medical-officer/"
  [15]=>
  string(19) "2020-03-27 09:15:59"
  ["add_date"]=>
  string(19) "2020-03-27 09:15:59"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:33"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}